SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-049546
Filing Date
2019-09-13
Accepted
2019-09-13 20:01:41
Documents
1
Period of Report
2019-09-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9729
  Complete submission text file 0001209191-19-049546.txt   11207
Mailing Address 12544 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Business Address 12544 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 8585521100
QUIDEL CORP /DE/ (Issuer) CIK: 0000353569 (see all company filings)

IRS No.: 942573850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences

Mailing Address 12544 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO CA 92130
Business Address
GIBSON KAREN (Reporting) CIK: 0001277462 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-10961 | Film No.: 191093517